Human induced pluripotent stem cell-derived neural stem cells survive, migrate, differentiate, and improve neurologic function in a rat model of middle cerebral artery occlusion

Stem Cell Research and Therapy

Volumn 4, Issue 3, 2013, Pages

  Yuan, Ting ^a   Liao, Wei ^b   Feng, Nian Hua ^b   Lou, Yuan Lei ^b   Niu, Xin ^a   Zhang, Ai Jun ^a   Wang, Yang ^a,b   Deng, Zhi Feng ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^b NANCHANG UNIVERSITY   (China)

Author keywords

Induced pluripotent stem cell; Middle cerebral artery occlusion; Neural stem cell; Stoke

Indexed keywords

BETA TUBULIN; GLIAL FIBRILLARY ACIDIC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; RETINOIC ACID; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; HOMEODOMAIN PROTEIN; NANOG PROTEIN, HUMAN; NESTIN; POU5F1 PROTEIN, HUMAN; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX; TUBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN ISCHEMIA; CELL CULTURE; CELL DIFFERENTIATION; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NANOG GENE; NERVE CELL; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; OCT4 GENE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SOX2 GENE; TREATMENT OUTCOME; ANIMAL; CONVALESCENCE; CYTOLOGY; DISEASE MODEL; EMBRYONIC STEM CELL; GENETICS; INFARCTION, MIDDLE CEREBRAL ARTERY; METABOLISM; MOTOR ACTIVITY; PATHOLOGY; SPRAGUE DAWLEY RAT; TRANSPLANTATION;

ANIMALIA; IPS; RATTUS;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EMBRYONIC STEM CELLS; HOMEODOMAIN PROTEINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MOTOR ACTIVITY; NESTIN; NEURAL STEM CELLS; NEURONS; OCTAMER TRANSCRIPTION FACTOR-3; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; SOXB1 TRANSCRIPTION FACTORS; TUBULIN;

EID: 84878895614     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt224     Document Type: Article

References (47)

1. Inducible pluripotent stem cells for the treatment of ischemic stroke: current status and problems. Zhu Y, Wan S, Zhan RY, Rev Neurosci 2012 23 393 402 23089605
2. Stem cells and stroke: are we further away than anyone is willing to admit? Savitz SI, Int J Stroke 2012 7 34 35 10.1111/j.1747-4949.2011.00724.x 22188852
3. Umbilical cord blood cells and brain stroke injury: bringing in fresh blood to address an old problem. Peterson DA, J Clin Invest 2004 114 312 314 15286794 (Pubitemid 39071600)
4. Combination treatment of stroke with sub-therapeutic doses of Simvastatin and human umbilical cord blood cells enhances vascular remodeling and improves functional outcome. Cui X, Chopp M, Zacharek A, Dai J, Zhang C, Yan T, Ning R, Roberts C, Shehadah A, Kuzmin-Nichols N, Sanberg CD, Chen J, Neuroscience 2012 227 223 231 23041512
5. Stem cell therapy: a clinical trial of stroke. Bhasin A, Padma Srivastava MV, Mohanty S, Bhatia R, Kumaran SS, Bose S, Clin Neurol Neurosurg 2012 115 1003 1008 23183251
6. Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Ikegame Y, Yamashita K, Hayashi S, Mizuno H, Tawada M, You F, Yamada K, Tanaka Y, Egashira Y, Nakashima S, Yoshimura S, Iwama T, Cytotherapy 2011 13 675 685 10.3109/14653249.2010.549122 21231804
7. The potential of stem cell therapy for stroke: is PISCES the sign? Smith HK, Gavins FN, FASEB J 2012 26 2239 2252 10.1096/fj.11-195719 22426119
8. The potential benefit of stem cell therapy after stroke: an update. Banerjee S, Williamson DA, Habib N, Chataway J, Vasc Health Risk Manag 2012 8 569 580 23091389
9. Bone marrow stromal cells enhance the angiogenesis in ischaemic cortex after stroke: involvement of notch signalling. Guo F, Lv S, Lou Y, Tu W, Liao W, Wang Y, Deng Z, Cell Biol Int 2012 36 997 1004 10.1042/CBI20110596 22866675
10. Bone marrow stromal cells promote skilled motor recovery and enhance contralesional axonal connections after ischemic stroke in adult mice. Liu Z, Li Y, Zhang RL, Cui Y, Chopp M, Stroke 2011 42 740 744 10.1161/STROKEAHA.110. 607226 21307396
11. Human neural stem cells can migrate, differentiate, and integrate after intravenous transplantation in adult rats with transient forebrain ischemia. Chu K, Kim M, Jeong SW, Kim SU, Yoon BW, Neurosci Lett 2003 343 129 133 10.1016/S0304-3940(03)00174-5 12759181 (Pubitemid 36577532)
12. Human neural stem cell transplantation promotes functional recovery in rats with experimental intracerebral hemorrhage. Jeong SW, Chu K, Jung KH, Kim SU, Kim M, Roh JK, Stroke 2003 34 2258 2263 10.1161/01.STR.0000083698.20199.1F 12881607 (Pubitemid 37099846)
13. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Bjorklund LM, Sanchez-Pernaute R, Chung S, Andersson T, Chen IY, McNaught KS, Brownell AL, Jenkins BG, Wahlestedt C, Kim KS, Isacson O, Proc Natl Acad Sci U S A 2002 99 2344 2349 10.1073/pnas.022438099 11782534 (Pubitemid 34169063)
14. Transplantation of human embryonic stem cell-derived neural precursor cells and enriched environment after cortical stroke in rats: cell survival and functional recovery. Hicks AU, Lappalainen RS, Narkilahti S, Suuronen R, Corbett D, Sivenius J, Hovatta O, Jolkkonen J, Eur J Neurosci 2009 29 562 574 10.1111/j.1460-9568.2008.06599.x 19175403
15. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Takahashi K, Yamanaka S, Cell 2006 126 663 676 10.1016/j.cell.2006.07.024 16904174 (Pubitemid 44233629)
16. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Hanna J, Markoulaki S, Schorderet P, Carey BW, Beard C, Wernig M, Creyghton MP, Steine EJ, Cassady JP, Foreman R, Lengner CJ, Dausman JA, Jaenisch R, Cell 2008 133 250 264 10.1016/j.cell.2008.03.028 18423197 (Pubitemid 351508307)
17. Reprogrammed mouse fibroblasts differentiate into cells of the cardiovascular and hematopoietic lineages. Schenke-Layland K, Rhodes KE, Angelis E, Butylkova Y, Heydarkhan-Hagvall S, Gekas C, Zhang R, Goldhaber JI, Mikkola HK, Plath K, MacLellan WR, Stem Cells 2008 26 1537 1546 10.1634/stemcells.2008- 0033 18450826
18. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, Croft GF, Saphier G, Leibel R, Goland R, Wichterle H, Henderson CE, Eggan K, Science 2008 321 1218 1221 10.1126/science.1158799 18669821
19. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Wernig M, Zhao JP, Pruszak J, Hedlund E, Fu D, Soldner F, Broccoli V, Constantine-Paton M, Isacson O, Jaenisch R, Proc Natl Acad Sci U S A 2008 105 5856 5861 10.1073/pnas.0801677105 18391196 (Pubitemid 351758462)
20. Functional improvement of focal cerebral ischemia injury by subdural transplantation of induced pluripotent stem cells with fibrin glue. Chen SJ, Chang CM, Tsai SK, Chang YL, Chou SJ, Huang SS, Tai LK, Chen YC, Ku HH, Li HY, Chiou SH, Stem Cells Dev 2010 19 1757 1767 10.1089/scd.2009.0452 20192839
21. Tridermal tumorigenesis of induced pluripotent stem cells transplanted in ischemic brain. Kawai H, Yamashita T, Ohta Y, Deguchi K, Nagotani S, Zhang X, Ikeda Y, Matsuura T, Abe K, J Cereb Blood Flow Metab 2010 30 1487 1493 10.1038/jcbfm.2010.32 20216552
22. Retinoic-acid-concentration-dependent acquisition of neural cell identity during in vitro differentiation of mouse embryonic stem cells. Okada Y, Shimazaki T, Sobue G, Okano H, Dev Biol 2004 275 124 142 10.1016/j.ydbio.2004. 07.038 15464577 (Pubitemid 39302616)
23. Regulation of mouse embryonic stem cell neural differentiation by retinoic acid. Kim M, Habiba A, Doherty JM, Mills JC, Mercer RW, Huettner JE, Dev Biol 2009 328 456 471 10.1016/j.ydbio.2009.02.001 19217899
24. A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration. Koch P, Opitz T, Steinbeck JA, Ladewig J, Brustle O, Proc Natl Acad Sci U S A 2009 106 3225 3230 10.1073/pnas.0808387106 19218428
25. Adherent self-renewable human embryonic stem cell-derived neural stem cell line: functional engraftment in experimental stroke model. Daadi MM, Maag AL, Steinberg GK, PLoS One 2008 3 1644 10.1371/journal.pone.0001644 18286199 (Pubitemid 351865462)
26. Enhanced efficiency of generating induced pluripotent stem (iPS) cells from human somatic cells by a combination of six transcription factors. Liao J, Wu Z, Wang Y, Cheng L, Cui C, Gao Y, Chen T, Rao L, Chen S, Jia N, Dai H, Xin S, Kang J, Pei G, Xiao L, Cell Res 2008 18 600 603 10.1038/cr.2008.51 18414447 (Pubitemid 351630949)
27. Reversible middle cerebral artery occlusion without craniectomy in rats. Longa EZ, Weinstein PR, Carlson S, Cummins R, Stroke 1989 20 84 91 10.1161/01.STR.20.1.84 2643202 (Pubitemid 19040218)
28. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. Willing AE, Lixian J, Milliken M, Poulos S, Zigova T, Song S, Hart C, Sanchez-Ramos J, Sanberg PR, J Neurosci Res 2003 73 296 307 10.1002/jnr.10659 12868063 (Pubitemid 36918093)
29. Stereotaxis of the rat brain in ontogenesis. Vozeh F, Rokyta R, Ruzickova A, Act Nerv Super 1979 21 5 7 (Pubitemid 9165612)
30. Resolution of stroke deficits following contralateral grafts of conditionally immortal neuroepithelial stem cells. Veizovic T, Beech JS, Stroemer RP, Watson WP, Hodges H, Stroke 2001 32 1012 1019 10.1161/01.STR.32.4. 1012 11283405 (Pubitemid 32285176)
31. Functional outcome in rats transferred to an enriched environment 15 days after focal brain ischemia. Johansson BB, Stroke 1996 27 324 326 10.1161/01.STR.27.2.324 8571431 (Pubitemid 26044508)
32. Environmental enrichment brings a beneficial effect on beam walking and enhances the migration of doublecortin-positive cells following striatal lesions in rats. Urakawa S, Hida H, Masuda T, Misumi S, Kim TS, Nishino H, Neuroscience 2007 144 920 933 10.1016/j.neuroscience.2006.10.038 17161913 (Pubitemid 46013998)
33. In vitro differentiation of embryonic stem cells into glial cells and functional neurons. Fraichard A, Chassande O, Bilbaut G, Dehay C, Savatier P, Samarut J, J Cell Sci 1995 108 3181 3188 7593279
34. Embryonic stem cells express neuronal properties in vitro. Bain G, Kitchens D, Yao M, Huettner JE, Gottlieb DI, Dev Biol 1995 168 342 357 10.1006/dbio.1995.1085 7729574
35. Differentiation of pluripotent embryonic stem cells into the neuronal lineage in vitro gives rise to mature inhibitory and excitatory neurons. Strubing C, Ahnert-Hilger G, Shan J, Wiedenmann B, Hescheler J, Wobus AM, Mech Dev 1995 53 275 287 10.1016/0925-4773(95)00446-8 8562428
36. An improved protocol that induces human embryonic stem cells to differentiate into neural cells in vitro. Zhou JM, Chu JX, Chen XJ, Cell Biol Int 2008 32 80 85 10.1016/j.cellbi.2007.08.015 17945517 (Pubitemid 351249142)
37. Neural differentiation from human embryonic stem cells in a defined adherent culture condition. Baharvand H, Mehrjardi NZ, Hatami M, Kiani S, Rao M, Haghighi MM, Int J Dev Biol 2007 51 371 378 10.1387/ijdb.072280hb 17616926 (Pubitemid 47320209)
38. Embryonic stem cell-derived neurogenesis: retinoic acid induction and lineage selection of neuronal cells. Guan K, Chang H, Rolletschek A, Wobus AM, Cell Tissue Res 2001 305 171 176 10.1007/s004410100416 11545254 (Pubitemid 32681894)
39. Development of neuronal precursor cells and functional postmitotic neurons from embryonic stem cells in vitro. Okabe S, Forsberg-Nilsson K, Spiro AC, Segal M, McKay RD, Mech Dev 1996 59 89 102 10.1016/0925-4773(96)00572-2 8892235 (Pubitemid 26325462)
40. Human neural precursor cells express low levels of telomerase in vitro and show diminishing cell proliferation with extensive axonal outgrowth following transplantation. Ostenfeld T, Caldwell MA, Prowse KR, Linskens MH, Jauniaux E, Svendsen CN, Exp Neurol 2000 164 215 226 10.1006/exnr.2000.7427 10877932 (Pubitemid 30490739)
41. Neural stem cells and neurospheres: re-evaluating the relationship. Reynolds BA, Rietze RL, Nat Methods 2005 2 333 336 10.1038/nmeth758 15846359 (Pubitemid 41130977)
42. Defining the actual sensitivity and specificity of the neurosphere assay in stem cell biology. Singec I, Knoth R, Meyer RP, Maciaczyk J, Volk B, Nikkhah G, Frotscher M, Snyder EY, Nat Methods 2006 3 801 806 10.1038/nmeth926 16990812 (Pubitemid 44445827)
43. Neural stem/progenitor cells as a promising candidate for regenerative therapy of the central nervous system. Bonnamain V, Neveu I, Naveilhan P, Front Cell Neurosci 2012 6 17 22514520
44. MCP-1, MIP-1, IL-8 and ischemic cerebral tissue enhance human bone marrow stromal cell migration in interface culture. Wang L, Li Y, Chen X, Chen J, Gautam SC, Xu Y, Chopp M, Hematology 2002 7 113 117 10.1080/10245330290028588 12186702 (Pubitemid 34692996)
45. VEGF is a chemoattractant for FGF-2-stimulated neural progenitors. Zhang H, Vutskits L, Pepper MS, Kiss JZ, J Cell Biol 2003 163 1375 1384 10.1083/jcb.200308040 14691144 (Pubitemid 38032097)
46. Modification of the brain-derived neurotrophic factor gene: a portal to transform mesenchymal stem cells into advantageous engineering cells for neuroregeneration and neuroprotection. Zhao LX, Zhang J, Cao F, Meng L, Wang DM, Li YH, Nan X, Jiao WC, Zheng M, Xu XH, Pei XT, Exp Neurol 2004 190 396 406 10.1016/j.expneurol.2004.06.025 15530878 (Pubitemid 39504994)
47. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Chen J, Zhang ZG, Li Y, Wang L, Xu YX, Gautam SC, Lu M, Zhu Z, Chopp M, Circ Res 2003 92 692 699 10.1161/01.RES.0000063425.51108.8D 12609969 (Pubitemid 36417705)